November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Hyperbaric oxygen improves healing in stressed animals
November 1st 2005Hyperbaric oxygen almost completely reverses the delay in wound healing caused by chronic stress and restores normal patterns of healing in mice, according to Phillip T. Marucha, D.M.D., Ph.D., a researcher at the University of Illinois at Chicago.
New Acne-Treatment Guidelines Favor Topical Retinoids
November 1st 2005Washington--The Global Alliance to Improve Outcomes in Acne has issued new acne-treatment guidelines that emphasize the importance of topical retinoid agents in treating lesions and acne precursors, and caution against the overuse of oral antibiotics.
Make the most of wound-healing process
October 21st 2005The importance of sound wound-healing techniques cannot be overestimated in the practice of dermatology. Patients desire treatments that heal scarring and wounds effectively but that don't require long periods of treatment and recovery time. Sometimes that's a challenge, and top practitioners are seeking ways to meet it.
Reloxin effects comparable to Botox
October 21st 2005Europe's version of Botox, Dysport (Ibsen-Biotech Laboratories) is poised to officially cross the Atlantic, mainly into the offices of U.S. cosmetic surgeons, once Food and Drug Administration (FDA) approval is obtained by its U.S. marketer, Santa Barbara, Calif.-based Inamed.
Botulinum toxin popularity surges; non-cosmetic applications emerging
October 21st 2005Chicago — The popularity of botulinum toxin type A injections for correcting wrinkles of the upper face has increased dramatically over the past few years. The extent of its popularity as a cosmetic procedure is obvious when this statistic is considered: The number of botulinum toxin type A procedures rose 157 percent from 2002 to 2003; the next highest increase was chemical peels, which rose a relatively sparse 48 percent over that same period.
Combining products benefits soft tissue augmentation
October 21st 2005In Dr. Baumann's experience, Sculptra is safe and effective for off-label cosmetic use alone or in combination with other fillers. The nature of the product makes it suitable not just for filling wrinkles, but for changing the structure of the face.
Arden, Allergan team-up to market 'new' Prevage
October 4th 2005New York - In what is believed to be the first product collaboration between a cosmetics company and a drug, Elizabeth Arden Inc. and Allergan Inc., the pharmaceutical firm that markets and distributes Botox, have teamed up to market a reformulated version of Allergan's anti-aging product, Prevage.